circana glp-1 Medication Usage is Impacting the U.S. Apparel Industry Personalization and GLP-1 Users: New

doi: 10.1016/j.tem.2020.02.009 8 OkunogbeANugentRSpencerGPowisJRalstonJWildingJet al

Currently, NICE guidance addresses the use of these medications for weight management through specific technology appraisals, though there is limited guidance specifically for post-bariatric weight regain

What to look for: Providers with Obesity Medicine training (check ABOM.org to find one near you) Endocrinologists or cardiometabolic specialists Primary care clinicians who focus on obesity care Why this matters: Provider comfort with dose titration, side-effect management, and long-term follow-up improves care quality and outcomes

When you do restart, your surgeon may recommend beginning at a lower dose than you were taking, then titrating back up as your body adjusts